Skip to content
    AZN stock page

    ASTRAZENECA PLC

    AZN · earnings call history

    1 call analysed
    1. Sep 2025Q3 FY25Nov 06, 2025

      AstraZeneca Q3 FY25 — Broad-based growth powers unprecedented catalyst run toward $80B 2030 ambition

      Read the brief

    Browse all US companies on the earnings-call register.